Articles

Yourway intends to construct a new manufacturing facility in the Dublin Airport Logistics Park.

Yourway Announces New European Depot in Dublin

The deal will see Spectrum market and distribute ANGUS’ biologics grade buffers in the United States and Canada.

Spectrum Chemical Strikes Buffers Distribution Deal with ANGUS Chemical Company

Precision BioSciences has released clinical trial data on CAR T therapy candidates PBCAR0191, PBCAR19B, and PBCAR269A.

Precision BioSciences Releases Data on CAR T Therapy Candidates

Moderna’s mRNA-1273.214 booster candidate exhibited an eight-fold boost in neutralizing geometric mean titers against Omicron.

Moderna Bivalent Booster Candidate Demonstrates Superior Antibody Response Against Omicron

REGENXBIO has opened a new in-house facility at its headquarters in Rockville, Md., that will be used to manufacture AAV gene therapies at commercial scale.

REGENXBIO Launches New Gene Therapy Manufacturing Facility in US

In the report, the agency presents the activities it accomplished in 2021 to protect and promote public health.

EMA Publishes 2021 Annual Report

Astellas Pharma has opened its new gene therapy manufacturing facility in Sanford, NC, which will support clinical- and commercial-scale manufacturing of AAV vectors for gene therapies.

Astellas Opens New US-based Large-Scale Gene Therapy Manufacturing Facility

The expansion at Seqirus’ Holly Springs, N.C., manufacturing facility will support the formulation and fill/finish of influenza vaccines.

Seqirus Announces Completion of $156 Million Expansion of Vaccine Manufacturing Facility

The European Commission has granted conditional marketing authorization to the Janssen Pharmaceutical Companies of Johnson & Johnson for CARVYKTI (ciltacabtagene autoleucel), a cell therapy for treating multiple myeloma.

J&J Receives EC Conditional Approval for its First Cell Therapy Product for Multiple Myeloma

The agency’s Medicines Shortages Steering Group has adopted a list of critical COVID-19 vaccines and treatments so they may be monitored for potential shortages.

News